logo True scholar network
Back to Top
Visit Website

OncoTargets and Therapy (OTT)

Publisher :

Taylor & Francis

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • Novel therapeutic regimens
  • Novel therapeutic targets
  • innovative agents

    • +4

e-ISSN :

1178-6930

Issue Frequency :

Continuously

Impact Factor :

2.7

Est. Year :

2008

Mobile :

4402080520500

DOI :

YES

Country :

United Kingdom

Language :

English

APC :

YES

Impact Factor Assignee :

GOOGLE SCHOLAR

Email :

enquiries@taylorandfrancis.com

Journal Descriptions

OncoTargets and Therapy is an international, peer-reviewed journal focusing on molecular aspects of cancer research, that is, the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. The journal is characterized by the rapid reporting of high-quality original research, basic science, reviews and evaluations, expert opinion and commentary that shed novel insight on a cancer or cancer subtype. OncoTargets and Therapy will no longer consider meta-analyses for publication. Specific topics covered by the journal include: Novel therapeutic targets and innovative agents Novel therapeutic regimens for improved benefit and/or decreased side effects Early stage clinical trials Further considerations when submitting to OncoTargets and Therapy: Studies containing in vivo animal model data will be considered favorably. Tissue microarray analyses will not be considered except in cases where they are supported by comprehensive biological studies involving multiple cell lines. Biomarker association studies will be considered only when validated by comprehensive in vitro data and analysis of human tissue samples. Studies utilizing publicly available data (e.g. GWAS/TCGA/GEO etc.) should add to the body of knowledge about a specific disease or relevant phenotype and must be validated using the authors' own data through replication in an independent sample set and functional follow-up. Bioinformatics studies must be validated using the authors' own data through replication in an independent sample set and functional follow-up. Single nucleotide polymorphism (SNP) studies will not be considered.


OncoTargets and Therapy (OTT) is :

International, Peer-Reviewed, Open Access, Refereed, Novel therapeutic regimens, Novel therapeutic targets, innovative agents, Early stage clinical trials, vivo animal model data, Bioinformatics studies, Single nucleotide polymorphism , Online Continuously Journal

UGC Approved, ISSN Approved: P-ISSN , E-ISSN - 1178-6930, Established in - 2008, Impact Factor - 2.7

Provide Crossref DOI

Indexed in Scopus, WoS

Not indexed in DOAJ, PubMed, UGC CARE

Indexing

Scopus Profile
Scopus
Scopus Profile
WoS
Scopus Profile
Crossref

+1 More

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile